End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | -2.67% | -39.17% | -95.16% |
Apr. 15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
2023 | Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
Financials (USD)
Sales 2022 | 119M | Sales 2023 | 118M | Capitalization | 529K |
---|---|---|---|---|---|
Net income 2022 | -65M | Net income 2023 | -253M | EV / Sales 2022 | - |
Net Debt 2022 | 135M | Net Debt 2023 | 161M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.23
x | P/E ratio 2023 |
-0.07
x | Employees | 102 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.29% |
Latest transcript on Acorda Therapeutics, Inc.
1 day | -2.67% | ||
Current month | -94.47% | ||
1 month | -94.58% | ||
3 months | -95.51% | ||
6 months | -92.71% | ||
Current year | -95.16% |
1st Jan change | Capi. | |
---|---|---|
-95.16% | 529K | |
-2.44% | 103B | |
+1.74% | 95.28B | |
+1.46% | 22.15B | |
-15.77% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.04% | 16.05B | |
+5.34% | 13.68B | |
+34.35% | 12.17B |
- Stock Market
- Equities
- ACOR.Q Stock